← Open Payments lookup

ERIC GOLDERMAN: Open Payments

NPI 1639784523 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$488 in 25 payments from 12 companies in 2025. Trend: 2023 $311 · 2024 $908 · 2025 $488

Food & beverage: $488
CompanyPaymentsAmount
ABBVIE INC.5$99
AstraZeneca Pharmaceuticals LP4$84
Novo Nordisk Inc4$82
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$66
Lilly USA, LLC2$27
Boehringer Ingelheim Pharmaceuticals, Inc.1$27
Astellas Pharma US Inc1$23
GlaxoSmithKline, LLC.1$19
Exact Sciences Corporation1$16
Daiichi Sankyo Inc.1$16

Products named: VRAYLAR, XIFAXAN, BREZTRI, MOUNJARO, Veozah, FARXIGA, Ozempic, Wegovy.

Industry payments across NY — which companies pay providers there.